Real-time enrollment status for this cardiomyopathy, hypertrophic obstructive clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 4:37 AM UTC
| NCT Number | NCT07755904 |
| Recruiting Status | Recruiting |
| Condition | Cardiomyopathy, Hypertrophic Obstructive |
| Phase | PHASE3 |
| Target Enrollment | 210 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Braveheart Bio, Inc. |
| Last Updated on CT.gov | October 2, 2026 (2 weeks ago) |
As of October 18, 2026: Clinical trial NCT07755904 is currently recruiting participants. This phase3 study for cardiomyopathy, hypertrophic obstructive is actively seeking new participants at 3 locations across the United States. The study is sponsored by Braveheart Bio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07755904 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07755904 was last updated 2 weeks ago (October 2, 2026). HelloStudys verifies this status automatically.